156 related articles for article (PubMed ID: 38630184)
21. Lin28 mediates paclitaxel resistance by modulating p21, Rb and Let-7a miRNA in breast cancer cells.
Lv K; Liu L; Wang L; Yu J; Liu X; Cheng Y; Dong M; Teng R; Wu L; Fu P; Deng W; Hu W; Teng L
PLoS One; 2012; 7(7):e40008. PubMed ID: 22808086
[TBL] [Abstract][Full Text] [Related]
22. Functional role of peroxisome-proliferator-activated receptor γ in hepatocellular carcinoma.
Wu CW; Farrell GC; Yu J
J Gastroenterol Hepatol; 2012 Nov; 27(11):1665-9. PubMed ID: 22742931
[TBL] [Abstract][Full Text] [Related]
23. Peroxisome proliferator-activated receptor gamma inhibition prevents adhesion to the extracellular matrix and induces anoikis in hepatocellular carcinoma cells.
Schaefer KL; Wada K; Takahashi H; Matsuhashi N; Ohnishi S; Wolfe MM; Turner JR; Nakajima A; Borkan SC; Saubermann LJ
Cancer Res; 2005 Mar; 65(6):2251-9. PubMed ID: 15781638
[TBL] [Abstract][Full Text] [Related]
24. LIN28: a regulator of tumor-suppressing activity of let-7 microRNA in human breast cancer.
Sakurai M; Miki Y; Masuda M; Hata S; Shibahara Y; Hirakawa H; Suzuki T; Sasano H
J Steroid Biochem Mol Biol; 2012 Sep; 131(3-5):101-6. PubMed ID: 22081076
[TBL] [Abstract][Full Text] [Related]
25. Computational investigation of phytochemicals from
Omoboyowa DA; Singh G; Fatoki JO; Oyeneyin OE
J Biomol Struct Dyn; 2023; 41(12):5568-5582. PubMed ID: 35773777
[TBL] [Abstract][Full Text] [Related]
26. Regulating Protein-RNA Interactions: Advances in Targeting the LIN28/Let-7 Pathway.
Oyejobi GK; Yan X; Sliz P; Wang L
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612395
[TBL] [Abstract][Full Text] [Related]
27. Polyamines are oncometabolites that regulate the LIN28/let-7 pathway in colorectal cancer cells.
Paz EA; LaFleur B; Gerner EW
Mol Carcinog; 2014 Feb; 53 Suppl 1():E96-106. PubMed ID: 23737330
[TBL] [Abstract][Full Text] [Related]
28. LT175 is a novel PPARα/γ ligand with potent insulin-sensitizing effects and reduced adipogenic properties.
Gilardi F; Giudici M; Mitro N; Maschi O; Guerrini U; Rando G; Maggi A; Cermenati G; Laghezza A; Loiodice F; Pochetti G; Lavecchia A; Caruso D; De Fabiani E; Bamberg K; Crestani M
J Biol Chem; 2014 Mar; 289(10):6908-6920. PubMed ID: 24451380
[TBL] [Abstract][Full Text] [Related]
29. Lin28 Regulates Cancer Cell Stemness for Tumour Progression.
Lin Z; Radaeva M; Cherkasov A; Dong X
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230562
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of Lin28 inhibits the proliferation, migration and cell cycle progression and induces apoptosis of BGC-823 gastric cancer cells.
Song H; Xu W; Song J; Liang Y; Fu W; Zhu XC; Li C; Peng JS; Zheng JN
Oncol Rep; 2015 Feb; 33(2):997-1003. PubMed ID: 25515921
[TBL] [Abstract][Full Text] [Related]
31. Stepwise assembly of multiple Lin28 proteins on the terminal loop of let-7 miRNA precursors.
Desjardins A; Bouvette J; Legault P
Nucleic Acids Res; 2014 Apr; 42(7):4615-28. PubMed ID: 24452802
[TBL] [Abstract][Full Text] [Related]
32.
Borgelt L; Hohnen L; Pallesen JS; Hommen P; Goebel GL; Bosica F; Liu Y; O'Mahony G; Wu P
ACS Med Chem Lett; 2023 Dec; 14(12):1707-1715. PubMed ID: 38116413
[TBL] [Abstract][Full Text] [Related]
33. A nanobody targeting the LIN28:let-7 interaction fragment of TUT4 blocks uridylation of let-7.
Yu C; Wang L; Rowe RG; Han A; Ji W; McMahon C; Baier AS; Huang YC; Marion W; Pearson DS; Kruse AC; Daley GQ; Wu H; Sliz P
Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4653-4663. PubMed ID: 32060122
[TBL] [Abstract][Full Text] [Related]
34. A novel C19MC amplified cell line links Lin28/let-7 to mTOR signaling in embryonal tumor with multilayered rosettes.
Spence T; Perotti C; Sin-Chan P; Picard D; Wu W; Singh A; Anderson C; Blough MD; Cairncross JG; Lafay-Cousin L; Strother D; Hawkins C; Narendran A; Huang A; Chan JA
Neuro Oncol; 2014 Jan; 16(1):62-71. PubMed ID: 24311633
[TBL] [Abstract][Full Text] [Related]
35. Live cell screening to identify RNA-binding small molecule inhibitors of the pre-let-7-Lin28 RNA-protein interaction.
Rosenblum SL; Soueid DM; Giambasu G; Vander Roest S; Pasternak A; DiMauro EF; Simov V; Garner AL
RSC Med Chem; 2024 May; 15(5):1539-1546. PubMed ID: 38784453
[TBL] [Abstract][Full Text] [Related]
36. Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios.
Katoch S; Sharma V; Patial V
World J Gastroenterol; 2022 Jul; 28(28):3535-3554. PubMed ID: 36161051
[TBL] [Abstract][Full Text] [Related]
37. Lin28: an emerging important oncogene connecting several aspects of cancer.
Wang H; Zhao Q; Deng K; Guo X; Xia J
Tumour Biol; 2016 Mar; 37(3):2841-8. PubMed ID: 26762415
[TBL] [Abstract][Full Text] [Related]
38. Disturbance of the let-7/LIN28 double-negative feedback loop is associated with radio- and chemo-resistance in non-small cell lung cancer.
Yin J; Zhao J; Hu W; Yang G; Yu H; Wang R; Wang L; Zhang G; Fu W; Dai L; Li W; Liao B; Zhang S
PLoS One; 2017; 12(2):e0172787. PubMed ID: 28235063
[TBL] [Abstract][Full Text] [Related]
39. In silico identification of potential drug compound against Peroxisome proliferator-activated receptor-gamma by virtual screening and toxicity studies for the treatment of Diabetic Nephropathy.
Singh S; Mohanty A
J Biomol Struct Dyn; 2018 May; 36(7):1776-1787. PubMed ID: 28539091
[TBL] [Abstract][Full Text] [Related]
40. Lin28 mediates radiation resistance of breast cancer cells via regulation of caspase, H2A.X and Let-7 signaling.
Wang L; Yuan C; Lv K; Xie S; Fu P; Liu X; Chen Y; Qin C; Deng W; Hu W
PLoS One; 2013; 8(6):e67373. PubMed ID: 23840685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
